GlassScriptPhysician profile
Kyle T Bradley
NPI 1023294071
$31,669.03
in general payments reported to CMS, 2019-2025
8 companies · $3,942 in 2025
The $3,942 reported for 2025 was more than what 93% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $11K · 2023: $10K · 2024: $6,867 · 2025: $3,942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Honoraria: $6,486 · Travel and Lodging: $1,641 · Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,537.00 |
| Honoraria | $6,485.62 |
| Travel and Lodging | $1,641.04 |
| Food and Beverage | $438.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sysmex America, INC. | $12,301.14 | 2022-2024 | Automated Hematology Analyzer Xn Series Xn-10 |
| E.R. Squibb & Sons, L.L.C. | $4,767.48 | 2022 | |
| Servier Pharmaceuticals LLC | $4,244.35 | 2024 | |
| Amgen INC. | $3,942.00 | 2025 | Uplizna |
| Abbvie INC. | $3,375.00 | 2023 | Venclexta |
| Daiichi Sankyo INC. | $2,220.00 | 2023 | |
| Celgene Corporation | $799.63 | 2022 | |
| Abbott Laboratories | $19.43 | 2024 | I-Stat |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.